Zoll Medical Corp. issues a reminder about a potential problem with the batteries in some of its automated external defibrillators, which may have played a role in the deaths of two people.
Zoll Medical Corp. (NSDQ:ZOLL) is reminding customers about defective batteries and a software glitch in one of its defibrillators that may have killed two people.
In April, the Chelmsford, Mass.-based resuscitation device maker issued a "voluntary worldwide field corrective action" on its AED Plus automated external defibrillator after discovering the problem.
Batteries in some of the devices made before Feb. 12 are defective and the software in the debrillators that's supposed to detect such problems doesn't work properly, the company said at the time. The roughly 180,000 affected devices carry serial numbers below "X_ _ _200000," according to the warning, and defibrillators older than three years — about 80,000 of them — are the most likely to fail.
On Dec. 21 Zoll issued a reminder about the problem, saying customers who haven't run a software upgrade and notified the company must do so immediately.
The problem initially came to light from customer reports, according to a press release, and "there has been one clinical event reported in which a defibrillation shock was not delivered [and] the patient subsequently died."
A subsequent review found that three other devices failed and, in one of those instances, a second patient later died.
The software defect can be fixed with a patch, available for download from the company's website, that can detect defective batteries and alert users.
Zoll said customers should take the following actions:
Warren Watson, a 30-year Medtronic Inc. employee with family connections to founder Earl Bakken, is...
Quidel Corp. wins Food & Drug Administration 510(k) clearance for its chorionic gonadotropin-...
Ann Arbor, Mich.-based HistoSonics Inc. snags former Food & Drug Administration commissioner Dr....
The Food & Drug Administration releases a list of the medical devices it granted 510(k) clearance...
A federal grand jury indicts former Spectranetics CEO John Schulte, two other executives and a...
Comments